The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a subject, pharmaceutical composition comprising such compounds (formula (I)), and their use as MCL-1 inhibitors, useful for treating diseases such as cancer.
本发明涉及用于治疗和/或预防受试者的药物剂,包括这些化合物(式(I)),以及它们作为MCL-1
抑制剂的药物组合物,用于治疗癌症等疾病。